Chapter/Section Purchase

1 Study Coverage
1.1 Cyclin Dependent Kinase 1 Product Introduction
1.2 Market by Type
1.2.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AT-7519
1.2.3 CD-650
1.2.4 Milciclib
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cyclin Dependent Kinase 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Relapsed Chronic Lymphocytic Leukemia
1.3.3 Gliosarcoma
1.3.4 Lymphoma
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cyclin Dependent Kinase 1 Sales Estimates and Forecasts 2017-2028
2.2 Global Cyclin Dependent Kinase 1 Revenue Estimates and Forecasts 2017-2028
2.3 Global Cyclin Dependent Kinase 1 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cyclin Dependent Kinase 1 Sales by Region
2.4.1 Global Cyclin Dependent Kinase 1 Sales by Region (2017-2022)
2.4.2 Global Sales Cyclin Dependent Kinase 1 by Region (2023-2028)
2.5 Global Cyclin Dependent Kinase 1 Revenue by Region
2.5.1 Global Cyclin Dependent Kinase 1 Revenue by Region (2017-2022)
2.5.2 Global Cyclin Dependent Kinase 1 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cyclin Dependent Kinase 1 Sales by Manufacturers
3.1.1 Global Top Cyclin Dependent Kinase 1 Manufacturers by Sales (2017-2022)
3.1.2 Global Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cyclin Dependent Kinase 1 in 2021
3.2 Global Cyclin Dependent Kinase 1 Revenue by Manufacturers
3.2.1 Global Cyclin Dependent Kinase 1 Revenue by Manufacturers (2017-2022)
3.2.2 Global Cyclin Dependent Kinase 1 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cyclin Dependent Kinase 1 Revenue in 2021
3.3 Global Cyclin Dependent Kinase 1 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cyclin Dependent Kinase 1 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cyclin Dependent Kinase 1 Sales by Type
4.1.1 Global Cyclin Dependent Kinase 1 Historical Sales by Type (2017-2022)
4.1.2 Global Cyclin Dependent Kinase 1 Forecasted Sales by Type (2023-2028)
4.1.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2017-2028)
4.2 Global Cyclin Dependent Kinase 1 Revenue by Type
4.2.1 Global Cyclin Dependent Kinase 1 Historical Revenue by Type (2017-2022)
4.2.2 Global Cyclin Dependent Kinase 1 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2017-2028)
4.3 Global Cyclin Dependent Kinase 1 Price by Type
4.3.1 Global Cyclin Dependent Kinase 1 Price by Type (2017-2022)
4.3.2 Global Cyclin Dependent Kinase 1 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cyclin Dependent Kinase 1 Sales by Application
5.1.1 Global Cyclin Dependent Kinase 1 Historical Sales by Application (2017-2022)
5.1.2 Global Cyclin Dependent Kinase 1 Forecasted Sales by Application (2023-2028)
5.1.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2017-2028)
5.2 Global Cyclin Dependent Kinase 1 Revenue by Application
5.2.1 Global Cyclin Dependent Kinase 1 Historical Revenue by Application (2017-2022)
5.2.2 Global Cyclin Dependent Kinase 1 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2017-2028)
5.3 Global Cyclin Dependent Kinase 1 Price by Application
5.3.1 Global Cyclin Dependent Kinase 1 Price by Application (2017-2022)
5.3.2 Global Cyclin Dependent Kinase 1 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cyclin Dependent Kinase 1 Market Size by Type
6.1.1 North America Cyclin Dependent Kinase 1 Sales by Type (2017-2028)
6.1.2 North America Cyclin Dependent Kinase 1 Revenue by Type (2017-2028)
6.2 North America Cyclin Dependent Kinase 1 Market Size by Application
6.2.1 North America Cyclin Dependent Kinase 1 Sales by Application (2017-2028)
6.2.2 North America Cyclin Dependent Kinase 1 Revenue by Application (2017-2028)
6.3 North America Cyclin Dependent Kinase 1 Market Size by Country
6.3.1 North America Cyclin Dependent Kinase 1 Sales by Country (2017-2028)
6.3.2 North America Cyclin Dependent Kinase 1 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cyclin Dependent Kinase 1 Market Size by Type
7.1.1 Europe Cyclin Dependent Kinase 1 Sales by Type (2017-2028)
7.1.2 Europe Cyclin Dependent Kinase 1 Revenue by Type (2017-2028)
7.2 Europe Cyclin Dependent Kinase 1 Market Size by Application
7.2.1 Europe Cyclin Dependent Kinase 1 Sales by Application (2017-2028)
7.2.2 Europe Cyclin Dependent Kinase 1 Revenue by Application (2017-2028)
7.3 Europe Cyclin Dependent Kinase 1 Market Size by Country
7.3.1 Europe Cyclin Dependent Kinase 1 Sales by Country (2017-2028)
7.3.2 Europe Cyclin Dependent Kinase 1 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cyclin Dependent Kinase 1 Market Size by Type
8.1.1 Asia Pacific Cyclin Dependent Kinase 1 Sales by Type (2017-2028)
8.1.2 Asia Pacific Cyclin Dependent Kinase 1 Revenue by Type (2017-2028)
8.2 Asia Pacific Cyclin Dependent Kinase 1 Market Size by Application
8.2.1 Asia Pacific Cyclin Dependent Kinase 1 Sales by Application (2017-2028)
8.2.2 Asia Pacific Cyclin Dependent Kinase 1 Revenue by Application (2017-2028)
8.3 Asia Pacific Cyclin Dependent Kinase 1 Market Size by Region
8.3.1 Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2017-2028)
8.3.2 Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cyclin Dependent Kinase 1 Market Size by Type
9.1.1 Latin America Cyclin Dependent Kinase 1 Sales by Type (2017-2028)
9.1.2 Latin America Cyclin Dependent Kinase 1 Revenue by Type (2017-2028)
9.2 Latin America Cyclin Dependent Kinase 1 Market Size by Application
9.2.1 Latin America Cyclin Dependent Kinase 1 Sales by Application (2017-2028)
9.2.2 Latin America Cyclin Dependent Kinase 1 Revenue by Application (2017-2028)
9.3 Latin America Cyclin Dependent Kinase 1 Market Size by Country
9.3.1 Latin America Cyclin Dependent Kinase 1 Sales by Country (2017-2028)
9.3.2 Latin America Cyclin Dependent Kinase 1 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Type
10.1.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Type (2017-2028)
10.2 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Application
10.2.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Application (2017-2028)
10.3 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country
10.3.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Astex Pharmaceuticals Inc
11.1.1 Astex Pharmaceuticals Inc Corporation Information
11.1.2 Astex Pharmaceuticals Inc Overview
11.1.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astex Pharmaceuticals Inc Recent Developments
11.2 ChoDang Pharm Co Ltd
11.2.1 ChoDang Pharm Co Ltd Corporation Information
11.2.2 ChoDang Pharm Co Ltd Overview
11.2.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ChoDang Pharm Co Ltd Recent Developments
11.3 Presage Biosciences Inc
11.3.1 Presage Biosciences Inc Corporation Information
11.3.2 Presage Biosciences Inc Overview
11.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Presage Biosciences Inc Recent Developments
11.4 Tiziana Life Sciences Plc
11.4.1 Tiziana Life Sciences Plc Corporation Information
11.4.2 Tiziana Life Sciences Plc Overview
11.4.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tiziana Life Sciences Plc Recent Developments
11.5 Tragara Pharmaceuticals Inc
11.5.1 Tragara Pharmaceuticals Inc Corporation Information
11.5.2 Tragara Pharmaceuticals Inc Overview
11.5.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tragara Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cyclin Dependent Kinase 1 Industry Chain Analysis
12.2 Cyclin Dependent Kinase 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cyclin Dependent Kinase 1 Production Mode & Process
12.4 Cyclin Dependent Kinase 1 Sales and Marketing
12.4.1 Cyclin Dependent Kinase 1 Sales Channels
12.4.2 Cyclin Dependent Kinase 1 Distributors
12.5 Cyclin Dependent Kinase 1 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cyclin Dependent Kinase 1 Industry Trends
13.2 Cyclin Dependent Kinase 1 Market Drivers
13.3 Cyclin Dependent Kinase 1 Market Challenges
13.4 Cyclin Dependent Kinase 1 Market Restraints
14 Key Findings in The Global Cyclin Dependent Kinase 1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer